(Q28544017)

English

Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign

scientific article (publication date: October 2014)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign (English)

0 references

infectious disease

0 references

Trypanosoma brucei

0 references

object named as

Emanuele Amata

4

0 references

Michael P. Pollastri

object named as

Michael P Pollastri

18

0 references

Gonzalo Colmenarejo

object named as

Gonzalo Colmenarejo

11

0 references

object named as

Miguel Navarro

17

0 references

5

object named as

William Devine

0 references

Domingo I Rojas-Barros

7

object named as

Domingo I Rojas-Barros

0 references

Rosario Díaz González

1

object named as

Rosario Diaz

0 references

Sandra A Luengo-Arratta

2

object named as

Sandra A Luengo-Arratta

0 references

3

object named as

João D Seixas

0 references

Carlos Cordon-Obras

6

object named as

Carlos Cordon-Obras

0 references

Manuela Pérez-Berlanga

14

object named as

Manuela Berlanga

0 references

author name string

Elena Jimenez

8

0 references

Fatima Ortega

9

0 references

Sabrinia Crouch

10

0 references

Jose Maria Fiandor

12

0 references

Jose Julio Martin

13

0 references

Silvia Gonzalez

15

0 references

Pilar Manzano

16

0 references

language of work or name

0 references

publication date

October 2014

0 references

PLoS Neglected Tropical Diseases

0 references

8

0 references

10

0 references

e3253

0 references

copyright license

Creative Commons Attribution 4.0 International

23 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Lapatinib-binding protein kinases in the African trypanosome: identification of cellular targets for kinase-directed chemical scaffolds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Thousands of chemical starting points for antimalarial lead identification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

19 March 2017

Ligand efficiency: a useful metric for lead selection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

7 April 2017

Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Target repurposing for neglected diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Innovative lead discovery strategies for tropical diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Protein kinases as drug targets in trypanosomes and Leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

HTS quality control and data analysis: a process to maximize information from a high-throughput screen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

High-throughput screening for kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

29 September 2017

Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4207660

3 June 2018

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003253

21 January 2018

Phenotypic vs. target-based drug discovery for first-in-class medicines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003253

21 January 2018

Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003253

21 January 2018

Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003253

21 January 2018

The influence of drug-like concepts on decision-making in medicinal chemistry

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003253

21 January 2018

Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to log P/log D

1 reference

https://pubmed.ncbi.nlm.nih.gov/25340575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25340575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/25340575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In silico ADMET traffic lights as a tool for the prioritization of HTS hits

1 reference

https://pubmed.ncbi.nlm.nih.gov/25340575

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0003253

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28544017&oldid=2125789904"